A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in China
A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in China
Recruiting · NCT07588880 · Registry updated 2026-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in China | progressive familial intrahepatic cholestasis type 1 | Recruiting | Not stated | 2026-10-01 | NCT07588880 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ipsen | 59 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Capital Children's Medical Center | Beijing | China | 1 |
| Children's Hospital of Fudan University Endocrinology and Metabolism | Shanghai | China | 1 |
| Chongqing Medical University - Children's Hospital | Chongqing | China | 1 |
| Hunan Children's Hospital | Hunan | China | 2 |
| Nanjing Medical University-Nanjing Children's Hospital | Nanjing | China | 1 |
| Xiamen Children's Hospital | Xiamen | China | 1 |